| |
| |
|
| Insider
Information: |
Duggan Robert W |
| Relationship: |
Chief Executive Office... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
594,894,754 |
|
|
Indirect Shares
|
1,046,059 |
|
|
| Direct
Value |
$2,785,202,344 |
|
|
|
Indirect Value
|
$8,213,619 |
|
|
| Total
Shares |
595,940,813 |
|
|
| Total
Value |
$2,793,415,963 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
19
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
14
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -0.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
318 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCYC |
Pharmacyclics Inc |
Chairman and CEO |
• • • |
2010-06-21 |
4 |
B |
$6.51 |
$6,999,995 |
D/D |
1,075,268 |
10,904,702 |
3.23 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2023-05-09 |
4 |
B |
$6.51 |
$65,249,320 |
D/D |
10,022,937 |
30,414,661 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2020-06-15 |
4 |
OE |
$7.01 |
$383,875 |
I/I |
54,761 |
321,805 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2020-06-15 |
4 |
OE |
$7.01 |
$17,574,855 |
D/D |
2,507,112 |
11,283,716 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2020-12-29 |
4 |
OE |
$7.01 |
$2,636,216 |
D/D |
376,065 |
11,659,781 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2020-12-29 |
4 |
OE |
$7.01 |
$57,580 |
I/I |
8,214 |
330,019 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman & CEO |
• • • |
2011-06-21 |
4 |
B |
$8.85 |
$6,000,300 |
D/D |
678,000 |
12,081,244 |
3.23 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-28 |
4 |
B |
$8.98 |
$1,117,085 |
D/D |
124,397 |
36,391,194 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-30 |
4 |
B |
$9.06 |
$1,385,673 |
I/I |
152,944 |
212,944 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-06 |
4 |
B |
$9.06 |
$750,286 |
D/D |
82,813 |
36,684,554 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-01 |
4 |
B |
$9.07 |
$413,592 |
I/I |
45,600 |
258,544 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-12 |
4 |
B |
$9.15 |
$164,691 |
D/D |
17,999 |
36,984,179 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-07 |
4 |
B |
$9.19 |
$687,890 |
D/D |
74,852 |
36,759,406 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-29 |
4 |
B |
$9.21 |
$552,600 |
I/I |
60,000 |
60,000 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-05 |
4 |
B |
$9.34 |
$616,636 |
I/I |
66,021 |
351,565 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-11 |
4 |
B |
$9.36 |
$843,504 |
D/D |
90,118 |
36,966,180 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-29 |
4 |
B |
$9.44 |
$1,497,184 |
D/D |
158,600 |
36,551,461 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-08 |
4 |
B |
$9.54 |
$1,112,898 |
D/D |
116,656 |
36,876,062 |
3.92 |
% |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-03-02 |
4 |
B |
$10.14 |
$981,683 |
D/D |
96,790 |
6,205,148 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-03-01 |
4 |
B |
$10.33 |
$4,243,285 |
D/D |
410,606 |
6,108,358 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-04 |
4 |
B |
$10.38 |
$280,260 |
I/I |
27,000 |
285,544 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-04 |
4 |
OE |
$10.66 |
$430,099 |
D/D |
40,347 |
36,591,808 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-02-28 |
4 |
B |
$10.70 |
$213,928 |
D/D |
20,000 |
5,697,752 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-01-03 |
4 |
B |
$10.89 |
$163,353 |
D/D |
15,000 |
5,617,752 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-02-14 |
4 |
B |
$10.96 |
$103,487 |
D/D |
9,442 |
5,677,752 |
2.45 |
- |
|
318 Records found
|
|
Page 7 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
